A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Eliminates Ex Vivo Reservoirs
Chang, L.-C.; Yin, M. T.; Laird, G. M.; Ritter, K. D.; Shah, J.; Debnath, A. K.
Show abstract
The persistence of latent HIV-1 proviruses in CD4+ T cells is a major obstacle to curing HIV. The "shock and kill" strategy involves reversing latency with latency-reversing agents (LRAs) and selectively inducing cell death in infected cells. However, current LRAs have shown limited efficacy in eliminating the ex vivo HIV reservoir. We repurposed PZ703b, a pro-apoptotic protein degrader initially developed for anti-leukemia therapy, to target HIV eradication. PZ703b induced degradation of Bcl-2 and Bcl-xL, activating the non-canonical NF-kB pathway and caspases cascade, resulting in latency reversal and selective apoptosis of infected cells. Treatment of ex vivo CD4+ T cells from ART-suppressed HIV-1 patients achieved a [~]50% reduction in the replication-competent reservoir. Our study provides proof-of-concept for using protein degraders to reverse HIV latency and induce cell death, highlighting PZ703bs potential in HIV cure strategies. This approach may pave the way for novel therapeutic interventions aimed at eliminating the HIV-inducible reservoir.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Induction of selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir 98%
- Identification of the Inducible HIV reservoir in Tonsillar, Intestinal and Cervical Tissue Models of HIV Latency 96%
- PADI4-mediated citrullination of histone H3 stimulates HIV-1 transcription 96%
Similar papers in this journal
- Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580 96%
- Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice 96%
- Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal 95%
Similar papers in this journal
- Identification of an antiretroviral small molecule that appears to be a host-targeting inhibitor of HIV-1 assembly 95%
- Anti-apoptotic clone 11 derived peptides induce in vitro death of CD4+ T cells susceptible to HIV-1 infection 95%
- A novel high throughput microwell outgrowth assay for HIV infected cells 94%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.